Process characterization using QbD approaches has rarely been described for precipitation steps used for impurity removal in biopharmaceutical processes. We propose a two-step approach for process characterization in which the first step focuses on product quality and the second focuses on process performance. This approach provides an efficient, streamlined strategy for the characterization of precipitation steps under the Quality by Design paradigm. This strategy is demonstrated by a case study for the characterization of a precipitation using sodium caprylate to reduce host cell proteins (HCP) during a monoclonal antibody purification process. Process parameters were methodically selected through a risk assessment based on prior development data and scientific knowledge described in the literature. The characterization studies used two multivariate blocks to decouple and distinguish the impact of product quality (e.g., measured HCP of the recovered product from the precipitation) and process performance (e.g., step yield). Robustness of the precipitation step was further demonstrated through linkage studies across the overall purification process. HCP levels could be robustly reduced to ≤100 ppm in the drug substance when the precipitation step operated within an operation space of ≤1% (m/v) sodium caprylate, pH 5.0-6.0, and filter flux ≤300 L/m 2 -hr for a load HCP concentration up to 19,000 ppm. This two-step approach for characterization of precipitation steps has several advantages, including tailoring of the experimental design and scale-down model to the intended purpose for each step, use of a manageable number of experiments without compromising scientific understanding, and limited time and material consumption.
establish a design space (a multivariate operational space that yields the desired product quality). This approach seeks to link the manufacturing process design and operation to product quality. [1] [2] [3] Development studies provide the scientific understanding to meet these goals. [1] [2] [3] In later phases of development (e.g., moving from clinical to commercial applications), the development studies are often referred to as process characterization. Process characterization studies demonstrate the impacts of individual or interacting process parameters over the intended operational space on product quality and process performance. [1] [2] [3] The choice of relevant process parameters is based on scientific assessments and identification of critical quality attributes (that need to be within specified ranges for appropriate safety and efficacy of a therapeutic). [1] [2] [3] Models based on mechanistic understanding and scientific first principles are preferred but they are less commonly used due to the complexity of the characterized unit operations (e.g., bioreactor systems, complex feeds into chromatography steps). Experimental execution yields empirical mathematical models obtained through univariate and multivariate experimental designs. [1] [2] [3] The results of these studies (unit operation centered or linking all production steps) are used to confirm the operational space, or on occasion, restrict or "refine" the operational space as a result of deeper process understanding. [1] [2] [3] Much has been published on the application of the QbD approaches for biopharmaceutical purification process characterization, especially on its application to chromatography steps. [4] [5] [6] [7] However, there is limited published information on the characterization of precipitation steps under the QbD paradigm. Precipitation is a method for impurity removal in biopharmaceutical processes [8] [9] [10] [11] [12] [13] [14] [15] that can be advantageous, because it is often simple, gentle, inexpensive (relative to chromatography), and scalable. 9, 12, [14] [15] [16] [17] [18] The published literature for characterization of precipitation steps has focused mostly on product quality. While some may explore process performance aspects of precipitation (e.g., sizing of filters for precipitate removal), the studies are not necessarily tailored to characterize and establish an appropriate control strategy as part of a manufacturing process. 9, 15, [19] [20] [21] Precipitation steps call for special considerations when it comes to the design of the scale-down models used for characterization studies that are unique to this mode of separation. While precipitation is seemingly simple (often a batch operation in simple tanks with impellers for mixing), it is actually complex to scale down/up. 22 The precipitation conditions in the scale-down model (e.g., pH, conductivity, final precipitant concentration, and temperature) need to be maintained at values representative of the full-scale process. [22] [23] [24] Vessel design (e.g., tank diameter to height ratio, impeller type and diameter, impeller placement, and baffle geometry) needs to mimic manufacturing scale tanks such that mixing (as defined by tip speed, power per volume ratio, shear, and/or residence time) results in the same precipitation endpoints (e.g., extent of precipitation and floc size distribution). [22] [23] [24] [25] Finally, the removal of the precipitate, for example (often by depth filtration, carries its own challenges. Depth filters are scaled by area ratio, but limitations in the scale-down model for filters leads to the consumption of large volumes of product. [22] [23] [24] [25] [26] Occasionally, filtration scale-down models are abandoned altogether and non-representative methods (such as benchtop centrifugation) are used instead. 22 Based on these considerations, characterization studies of precipitation steps are likely to require an extensive number of complex experiments and resources (personnel, time, material, data collection and analysis). We propose an alternative streamlined strategy for the characterization of precipitation steps using QbD principles. The strategy uses a two-step approach to multivariate experimental design, with the first step focused on product quality and the second focused on process performance. Additionally, this strategy allows the use different scaleddown models to reflect the relevant outputs being studied in each step, minimizing the complexity of the studies and use of resources. This strategy is demonstrated by a case study for the characterization studies of a precipitation step using sodium caprylate to reduce host cell proteins (HCP) during a monoclonal antibody purification process. Sodium caprylate can interact with other molecules due to both hydrophobic and polar properties. 14, 15, [27] [28] [29] Under acidic conditions, hydrophobicity dominates causing sodium caprylate to become unstable and precipitate along with acidic proteins (e.g., some HCP), while basic molecules (such as antibodies with basic pI) remain in solution. Results from the characterization studies using this two-step approach demonstrated effective and robust clearance of HCP. This was further verified using linkage studies in which the characterized precipitation step was included in the entire downstream process.
| MATERIALS AND METHODS

| Materials
| Antibody-containing product intermediate
The antibody was a human IgG 1 monoclonal antibody with a pI of 9.0-9.1 (range due to varying levels of charge variants) produced from CHO cell culture. The antibody-containing product intermediate was the eluted product from a cation-exchange chromatography that served as the capture step for the antibody purification process (see Methods below for description of the purification process). Antibody concentration in the starting material ranged from 6 to 15 mg/mL (depending on the operation of the cation-exchange chromatography) in 75 sodium phosphate buffer pH 6.5 with approximately 25 mM sodium chloride.
The antibody was >99% monomer by high-performance size-exclusion chromatography. The antibody-containing product used in the Step 1 study had 740 ppm HCP. The product used in the Step 2 study had HCP varying between 125 and 6,225 ppm (the varying HCP achieved through well understood method modifications in the cation-exchange chromatography operation). See Characterization of the precipitation step using a QbD approach below for description of Steps 1 and 2.
| Reagents
Sodium caprylate was obtained from EMD Millipore (Darmstadt, Germany). A 20% (mass/volume) stock solution was prepared by dissolving sodium caprylate in 10 mM sodium phosphate pH 6.5 solution.
Sodium chloride, sodium phosphate monobasic monohydrate, sodium phosphate anhydrous, sodium phosphate dibasic heptahydrate, sodium sulfate, Tris base, Tris hydrochloride, and glycine were obtained from Avantor Performance Materials (Center Valley, PA).
| Filters
Millistak+ pod grade X0HC (nominal retention <0.1 μm) and D0HC (nominal retention 0.6-9.0 μm) depth filters and Express SHC 0.5/0.2-μm sterilizing grade filters were purchased from EMD Millipore (Darmstadt, Germany).
| METHODS
| General description of the purification process
The antibody was produced and secreted by CHO cells cultivated in a fed-batch cell culture using proprietary in-house media, feeds, and bioreactor set points. Cells were separated from the cell culture fluid using a combination of continuous disc-stack centrifugation (Q/ istics of the product that should be within an appropriate limit, range or distribution to ensure the safety and efficacy of the drug 1-3 ) were HCP in the precipitated product and Drug Substance, monomer purity, and charge variants. The acceptable ranges for HCP in the antibody-containing product after the caprylate precipitation step and Drug Substance were ≤650 ppm and ≤100 ppm, respectively. The acceptable ranges for monomer purity and charge variants were ≥98% by high-performance size-exclusion chromatography and ≤10% by high-performance ion-exchange chromatography, respectively. Process performance measurements (step yield and filter capacity) were also studied as an added layer of control to ensure step consistency and manufacturing feasibility. The acceptable ranges for the process performance measurements were step yield >90% step yield and filter capacity >260 L/m 2 .
| Detailed description of the precipitation
2. Risk assessment -The potential impact of process parameters on product quality and process performance outputs involved in the precipitation step were scored as high, low, or no impact. Process parameters identified in the risk assessment as having potential impact on product quality and process performance were included in multivariate studies (see Characterization Study). Process parameter ranges studied can be found in Table 1. 3. Characterization Study -A two-step approach was used to further refine the multivariate study design and is illustrated in Figure 1 .
Step 1product quality. The impacts of the amount of sodium caprylate added, pH for precipitation, hold time, and temperature on product quality (HCP, monomer purity, and charge variants)
were determined using a multivariate full-factorial design of experiments (DOE) over the process parameter ranges as shown in Table 1 . This two-level, full-factorial study design comprised 18 experiments (including two center points using target values as described in the "Detailed description of the precipitation" for estimation of process variability). It determined all main effects and two-way interactions between process parameters. The design had 100% power for detecting differences in response of 2 SDs (see Table 2 ). Based on the chemistry of precipitation by sodium caprylate where precipitation of HCP is based on solution pH, amount of sodium caprylate, and molecule pI, the assessment of product quality required only that precipitation occurred. Thus, scaling of vessel design, mixing and filtration systems was not necessary, [22] [23] [24] [25] [26] and centrifuge tubes or small beakers with magnetic stir bars could be used.
Step 2-process performance. The impacts of filter flux, agitation rate, hold time, HCP in the starting material, amount of sodium caprylate added, and pH for precipitation on process performance on step yield and filter capacity were determined using a multivariate fractional-factorial DOE over the process parameter ranges given in Table 1 . This two-level, resolution IV study design had 14 experiments (including two center points for estimation of process variability) and determined all main effects and some two- be least effective at HCP clearance. The precipitated product was then purified through the remainder of the purification process as described in the General Description of the Purification Process, using target/typical running conditions. The HCP of the Drug Substance produced using this approach was compared to the Drug Substance using a typical HCP input into the precipitation step (1,300 ppm) and run through target precipitation conditions. Figure 2 illustrates the linkage study design.
| Analytical assays
Total protein concentration was measured by UV absorbance at 280 nm (Agilent, Santa Clara, CA). Monomer purity was measured by high-performance size-exclusion chromatography using a TSKgel 
| Statistical analysis
Multivariate design of experiments and statistical analysis was performed using JMP version 10 software (SAS, Cary, NC). 31 4 | RESULTS AND DISCUSSION
| Identification of relevant critical quality attributes to be part of the characterization studies
While severity risk assessments on the criticality of product attributes for a therapeutic antibody identify multiple critical quality attributes
Process parameters studied Outputs analyzed
Process parameters with significant impact (in bold above) were carried to Step 2
Step 1 Multivariate study Focused on product quality
Step 2 Multivariate study Focused on process performance 
| Risk assessment
Following a QbD-based approach, a risk assessment was performed to determine which process parameters made scientific sense to be further studied during characterization studies. Table 1 shows the process parameters associated with the precipitation step, the corresponding ranges that were assessed, the risk score associated with the extent of impact from each process parameter on the relevant outputs, and justification for the final scoring (highest identified for each process parameter). The parameter ranges were informed by prior knowledge from early process development and by manufacturing control capabilities, but some were also widened to better understand the process. Seven process parameters were identified as having potential impact on the product quality and process performance of the precipitation step and were included in the characterization studies: pH for precipitation, amount of caprylate added, temperature, hold time, agitation rate, filter flux, and HCP in the starting material. The two-step approach also allowed for selection of separate suitable scale-down models based on the intended purpose of each step.
| Characterization studies
Step 1 did not require the use of scale-down vessels or filters, so tubes and small beakers were used. This reduced the volume of product per experiment from 3-L (scaled-down mixing vessel) to <50 mL per condition studied. Additionally, experiments in Step 1 could be run in parallel, allowing for significant time savings. Meanwhile, Step 2 used scaled-down vessels and filters to mimic the actual clinical manufacturing facility. The pH for precipitation and amount of caprylate added had the most significant and substantial impacts on product quality of the four parameters studied in Step 1. Therefore, these parameters were carried to Step 2 for further evaluation in the process performance characterization, in addition to parameters that could impact process performance. Temperature was excluded from Step 2 characterization study as its influence on product quality was minimal. Although hold time also had minimal impact on product quality, it was included in 
| Step 1-product quality
Worst Case Typical F I G U R E 2 Linkage study design and results
Step 2 due to the identified potential impact to process performance, as described in the risk assessment (Table 1 ).
| Step 2-process performance
Similarly to the results from Step 1 (Figure 3) , Figure 4 Two interactions impacting the HCP in the product after the precipitation step (starting HCP and pH with amount of caprylate added) were found to be statistically significant. While these interactions
Charge Variants
Monomer Purity HCP Interpretation of Results: These results were consistent with the chemistry of precipitation of HCP, in which increasing sodium caprylate concentration and decreasing solution pH result in increasing HCP precipitation. 
Interpretation of Results:
Only the interaction between the amount of caprylate added and temperature was found to be statistically significant. However, the magnitude of the impact for all process parameters and interactions had minimal practical relevance (impacts were well within acceptable levels). 
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Interpretation of Results: Only the interaction between the amount of caprylate added and temperature was found to be statistically significant. However, the magnitude of the impact for all process parameters and interactions had minimal practical relevance (impacts were well within acceptable levels). 
Interpretation of Results:
Consistent with the chemistry of precipitation of HCP, as the caprylate concentration increased, the particulate load for the filters increased and filter capacity decreased. Similarly, increasing starting HCP and the interaction of decreasing increasing caprylate concentration resulted in increased particulate load to the filters and pH with substantial decrease in filter capacity, though these parameters/interactions were not statistically significant. 
As the starting level of HCP increased, the amount of HCP in the product also increased, suggesting a threshold of HCP in the feed for effective HCP clearance. The influence of this parameter dominates the analysis. Consistent with the analysis of product quality (Step 1) and the chemistry of precipitation of HCP, pH was significant. Unlike Step 1, the main effect of caprylate concentration was not significant, though its magnitude of impact was in alignment with Step 1 and its interactions with pH and starting HCP are significant. suggesting that the interactions that are shown (i.e., pH, amount of sodium caprylate added and HCP in the starting material) were descriptive of the process characterization. These findings were consistent with the scope of the study for each step and the chemistry of the precipitation step.
The HCP level in the starting material, pH for precipitation, and the amount of sodium caprylate added had the most significant and substantial impacts on process performance, as well as on product quality.
At some limits of these characterized ranges, HCP and step yield exceeded predetermined acceptable ranges (≤650 ppm and ≥90%, respectively) in the product. The HCP in the starting material was dependent on the operation of the cation-exchange chromatography step, and thus was controlled during the capture cation-exchange chromatography. The ranges for the other process parameters were controlled during the precipitation and thus these ranges could be limited to where impacts were found to be within the acceptable ranges (pH for precipitation pH 5.0-6.0 and amount of caprylate added).
Monomer purity and charge variant were monitored during Step 2. However, the techniques used to generate high HCP starting material used in Step 2 also resulted in high levels of aggregate (reduced monomer purity) and charge variants in the starting material. The monomer purity and charge variant levels in the product after the precipitation step were the same as the levels in the starting material (results not shown), showing these attributes were not impacted by the precipitation step process parameters within the ranges studied.
Statistical analysis of monomer purity and charge variants in the product would be confounded by the HCP level in the starting material and therefore were excluded from analysis during Step 2.
| Linkage study to determine process robustness
A linkage study was performed to verify the results from the characterization studies, to ensure that the precipitation was robust enough to handle typical variability of HCP in the starting material (125-6,225 ppm), and also result in HCP ≤100 ppm for the Drug Substance. The linkage study design and results are illustrated in Figure 2 . The results showed that even when the precipitation step was challenged with atypically high HCP (19,000 ppm) in the starting material and the precipitation was carried out at the least favorable conditions for HCP clearance, after two polishing steps the HCP was reduced to similar values to those obtained from typical starting material and well under the acceptable range of ≤100 ppm for Drug Substance.
| Operational space analysis
The HCP level in the starting material, pH for precipitation, and the amount of sodium caprylate added had the most significant and substantial impacts on process performance and product quality during the characterization studies. Therefore, the operational space for the precipitation unit operation would be defined based on these process parameters. As discussed above, the HCP in the starting material was dependent on the operation of the cation-exchange chromatography step, but the precipitation step was able to accommodate HCP in the starting material approximately three-fold higher than typical high HCP levels during normal process operation. The ranges for pH and the amount of sodium caprylate added could be controlled during the precipitation and thus could be limited to where impacts were found to be within the acceptable ranges for product quality and process performance. Figure 5 shows contour plots of the combined impacts of pH and amount of sodium caprylate added on HCP in the Drug Substance and step yield. The areas marked by the red borders denote a proposed example of an operational space in which the precipitation step yield is ≥90% and Drug Substance HCP levels are ≤100 ppm ( Figure 5a ). This operational space is limited to sodium caprylate concentration ≤1% (mass/volume) and pH 5.0-6.0. If (for illustrative purposes) a more conservative HCP limit of ≤70 ppm is used (Figure 5b) , the operational space is reduced to a pH range of 5.0-5.3. Since this was a multivariate study, one could arguably claim a Design Space (operational space within which any combination of the defined parameter ranges results in appropriate quality). The knowledge F I G U R E 5 Contour plots illustrating potential operational spaces for the precipitation unit operation. The operational space is influenced by the impacts of pH for precipitation and the amount of caprylate added on the precipitation step yield (blue) and HCP in the drug substance (pink). The red boxes denote example operational spaces where step yield is ≥90% and drug substance HCP is ≤100 ppm (a) or more conservatively ≤70 ppm (b) accumulated from this characterization exercise allowed for and successfully achieved the needed purity, even for HCP in the Drug Substance lower than 100 ppm.
| CONCLUSIONS
A two-step QbD-based approach to the characterization of precipitation steps was proposed and successfully demonstrated with a case study using sodium caprylate-induced precipitation of HCP.
The two-step approach sequentially addressed the impacts of process parameters on product quality (HCP, monomer, and charge variants) and then process performance (step yield, and filterability). Additionally, linkage studies verified the robustness of the The two-step strategy described here to characterize precipitation in a downstream process has already been adopted in-house, for precipitation that is forced through addition of components that induce floc formation (as presented here) as well as precipitation, which may manifest during biopharmaceutical manufacturing like the turbidity from a chromatography column effluent.
